Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoding Liu

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 19, 2026
Tumor-Derived LAMB3 Drives Immunosuppressive LRRC15<sup>+</sup> Fibroblast Formation During Pancreatic Ductal Adenocarcinoma DevelopmentXuqing Shi, Hangqi Liu, Jianru Sun, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2019
Prevalence of recurrent oncogenic fusion in mismatch repair-deficient colorectal carcinoma with hypermethylated MLH1 and wild-type BRAF and KRASJing Wang, Yuting Yi, Yi Xiao, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 19, 2026
Tumor-Derived LAMB3 Drives Immunosuppressive LRRC15<sup>+</sup> Fibroblast Formation During Pancreatic Ductal Adenocarcinoma DevelopmentXuqing Shi, Hangqi Liu, Jianru Sun, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2019
Prevalence of recurrent oncogenic fusion in mismatch repair-deficient colorectal carcinoma with hypermethylated MLH1 and wild-type BRAF and KRASJing Wang, Yuting Yi, Yi Xiao, et al.
Pageof 3